Could stem cell vesicles treat spinal cord cavities?
NCT ID NCT07295067
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This early-stage trial tests whether injections of tiny particles from umbilical cord stem cells are safe for people with syringomyelia, a condition where fluid-filled cavities form in the spinal cord. The study will enroll 18 adults whose symptoms haven't improved after surgery or natural shrinkage of the cavity. Participants receive three monthly injections into the spinal fluid, and researchers will monitor for side effects and any changes in spinal cord function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
extracellular vesicles from human umbilical cord blood mesenchymal stem cells
What this could lead to
If safe and effective, this could point toward a new treatment option for syringomyelia that may improve spinal cord function.
What could go wrong
This is a very early Phase 1 trial with only 18 participants, focused on safety. It may not show clear benefit, and there are risks of serious side effects from the injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYRINGOMYELIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuanwu Hospital
Beijing, Beijing City, 100032, China